Magnitude Biosciences

We are a specialist Contract Research Organisation (CRO) who help the biopharma and nutraceutical industries progress their preclinical research projects via our team of expert scientists, C. elegans services and unique automated imaging technology. Our C. elegans studies are customised to answer your key research questions and generate high-quality, reproducible data to accelerate your research. C. elegans has many useful applications for furthering toxicology and drug development research and, with the right technology, assays, and C. elegans expertise, these tiny worms are enabling big breakthroughs in R&D projects.

We work with biotech and pharma to derisk your drug progressing from in-vitro to mice. Using our C. elegans technology will tell you what chemical series is best used for your target, what the in-vivo toxicity of your favoured compound(s) are, which of your possible targets will work best in-vivo, and if your chemical series or compounds are effective in-vivo, at a fraction of the cost and time of using mice. For companies developing therapies to slow ageing or tackle age-related disease, there is no other method in the world that will, within just a few weeks, generate rich data on the efficacy of your compounds to slow ageing.